[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100498621":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":11,"centralContacts":20,"locations":30,"responsibleParty":50,"collaborators":11,"id":52,"slug":53,"hasResults":54,"nctId":55,"briefTitle":56,"officialTitle":56,"acronym":57,"eligibilityCriteria":58,"healthyVolunteers":54,"sex":59,"minAge":60,"maxAge":61,"enrollmentInfo":62,"targetDuration":11,"studyType":65,"phases":66,"briefSummary":68,"conditions":69,"keywords":71,"overallStatus":33,"whyStopped":11,"lastUpdateSubmitDate":75,"lastUpdatePostDateStruct":76,"startDateStruct":79,"completionDateStruct":81,"leadSponsor":83,"locationsCount":84},{"fullName":5,"class":6},"Assistance Publique - Hôpitaux de Paris","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"MS Patient with Bladder disorders","EXPERIMENTAL",null,[13],"Procedure: Repeated cystometries with bladder sensations assessment",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":11},"PROCEDURE","Repeated cystometries with bladder sensations assessment","A second cystometry will be performed to assess bladder sensations reliability. A third cystometry with cognitive task (STROOP test) at the same time will be performed to assess the impact of distractive attentional task on bladder sensations",[9],[21,27],{"name":22,"role":23,"phone":24,"phoneExt":25,"email":26},"Claire Hentzen, MD","CONTACT","0156017500","+33","claire.hentzen@aphp.fr",{"name":28,"role":23,"phone":24,"phoneExt":25,"email":29},"Gérard AMARENCO, MD, PhD","gerard.amarenco@aphp.fr",[31],{"facility":32,"status":33,"city":34,"state":35,"zip":36,"country":37,"countryCode":38,"cosmosGeoPoint":39,"geoPoint":44,"contacts":45},"Hôpital TENON","RECRUITING","Paris","Choisir Une Région","75020","France","FR",{"type":40,"coordinates":41},"Point",[42,43],2.3488,48.85341,{"lat":43,"lon":42},[46,48],{"name":47,"role":23,"phone":24,"phoneExt":11,"email":26},"Claire HENTZEN, MD",{"name":22,"role":49,"phone":11,"phoneExt":11,"email":11},"PRINCIPAL_INVESTIGATOR",{"type":51,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR","100498621","clinical-and-urodynamic-assessment-of-bladder-sensation-in-multiple-sclerosis-100498621",false,"NCT05772637","Clinical and Urodynamic Assessment of Bladder Sensation in Multiple Sclerosis","CUBS-MS","Inclusion Criteria:\n\n* Age ≥ 18\n* MS according to the 2017 Mac Donald diagnostic criteria\n* Bladder disorders supposedly related to MS\n* Indication to perform urodynamics\n* No current medication for bladder disorders\n* Able to understand and right in French\n* Affiliated to the \"Securite sociale\" or \"Couverture Medicale Universelle (CMU)\", or equivalent organism.\n\nExclusion criteria:\n\n* Legal protection\n* Pregnancy or breastfeeding mother\n* MS relapse during the past month\n* Other associated neurological disease\n* Genuine stress incontinence related to postpartum\n* Treatment with antimuscarinics, alpha blockers, beta3 adrenergic, or tibial nerve stimulation in the past 15 days, or with botulinic toxin injection in the past 6 months\n* Previous lower urinary tract surgery\n* Inability to use the analogic device due to motor, sensory or ataxic disabilities","ALL","18 Years","99 Years",{"count":63,"type":64},113,"ESTIMATED","INTERVENTIONAL",[67],"NA","The aim of the study is to assess the association between bladder sensations progression during bladder filling and severity of Overactive bladder (OAB) in patients with multiple sclerosis.",[70],"Overactive Bladder",[72,73,74],"overactive bladder","multiple sclerosis","bladder sensations","2026-03-04",{"date":77,"type":78},"2026-03-05","ACTUAL",{"date":80,"type":78},"2024-02-14",{"date":82,"type":64},"2027-02-14",{"name":5,"class":6},1]